We are so proud to announce the launch of a groundbreaking clinical study with IceCure Medical, making our network the 1st U.S. clinical site for the company’s ProSense® cryoablation technology. The ChoICE Study will evaluate the use of ProSense® cryoablation in low-risk breast cancer patients, enrolling approximately 400 patients across 30 clinical sites nationwide. This important research… Read more »